BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 20411367)

  • 21. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
    Cox CE; Nguyen K; Gray RJ; Salud C; Ku NN; Dupont E; Hutson L; Peltz E; Whitehead G; Reintgen D; Cantor A
    Am Surg; 2001 Jun; 67(6):513-9; discussion 519-21. PubMed ID: 11409797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy.
    Schulz S; Sinn P; Golatta M; Rauch G; Junkermann H; Schuetz F; Sohn C; Heil J
    Breast; 2013 Aug; 22(4):537-42. PubMed ID: 23237921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
    Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P
    Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sentinel lymph node biopsy is precise after primary systemic therapy in stage II-III breast cancer patients.
    Reitsamer R; Menzel C; Glueck S; Rettenbacher L; Weismann C; Hutarew G
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():286-90. PubMed ID: 20853048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.
    Sakr R; Antoine M; Barranger E; Dubernard G; Salem C; Daraï E; Uzan S
    Breast J; 2008; 14(1):55-60. PubMed ID: 18186866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy.
    Watanabe Y; Anan K; Saimura M; Koga K; Fujino M; Mine M; Tamiya S; Nishihara K; Nakano T; Mitsuyama S
    Breast Cancer; 2018 Nov; 25(6):663-670. PubMed ID: 29786772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
    Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of sentinel lymph node biopsy in ductal carcinoma in situ.
    Moran CJ; Kell MR; Kerin MJ
    Eur J Surg Oncol; 2005 Dec; 31(10):1105-11. PubMed ID: 16084681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ.
    Dominguez FJ; Golshan M; Black DM; Hughes KS; Gadd MA; Christian R; Lesnikoski BA; Specht M; Michaelson J; Smith BL
    Ann Surg Oncol; 2008 Jan; 15(1):268-73. PubMed ID: 17891441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of influencing factors to metastasis in sentinel lymph nodes and non-sentinel lymph nodes in breast cancer].
    Wang H; Wang J; Gao JD; Wu TC; Fang Y; Wang X
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):769-72. PubMed ID: 24378100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of sentinel lymph node detection by methylene blue and carbon nanoparticle suspension injection in early breast cancer].
    Ge J; Yan B; Cao XC
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):226-8. PubMed ID: 21575525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symmetrization reduction mammaplasty combined with sentinel node biopsy in patients operated for contralateral breast cancer.
    Schrenk P; Wölfl S; Bogner S; Huemer GM; Wayand W
    J Surg Oncol; 2006 Jul; 94(1):9-15. PubMed ID: 16788937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-step surgery for breast cancer: back to the future?
    Cody HS
    World J Surg; 2007 Jun; 31(6):1153-4. PubMed ID: 17440773
    [No Abstract]   [Full Text] [Related]  

  • 35. Indication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ.
    Miyake T; Shimazu K; Ohashi H; Taguchi T; Ueda S; Nakayama T; Kim SJ; Aozasa K; Tamaki Y; Noguchi S
    Am J Surg; 2011 Jul; 202(1):59-65. PubMed ID: 21741518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Importance of sentinel lymph node biopsy in surgical therapy of in situ breast cancer].
    Takács T; Szentpáli K; Paszt A; Ormándi K; Lázár M; Pálka I; Kahán Z; Lázár G
    Magy Onkol; 2006; 50(3):247-51. PubMed ID: 17099786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sentinel lymph node examination in breast carcinoma in situ].
    Mergancová J; Mergancová J; Hrncirová I; Kerekes Z; Hácová M
    Rozhl Chir; 2011 Jul; 90(7):393-6. PubMed ID: 22026090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel lymph node biopsy in the management of ductal carcinoma in situ.
    Zujewski J; Eng-Wong J
    Clin Breast Cancer; 2005 Aug; 6(3):216-22. PubMed ID: 16137431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sentinel lymph node biopsy in breast cancer: state of the art].
    Bauerfeind I; Himsl I; Kühn T; Untch M; Hepp H
    Gynakol Geburtshilfliche Rundsch; 2004 Apr; 44(2):84-91. PubMed ID: 15073437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Standards of pathohistologic processing of breast cancer. A contribution to quality assurance in pathology and patient care].
    Bässler R; Schnürch HG
    Gynakologe; 1994 Feb; 27(1):23-36. PubMed ID: 8168734
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.